{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:00:25Z","timestamp":1776168025342,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017363","name":"Hangzhou Agriculture and Social Development Research Funds","doi-asserted-by":"publisher","award":["20220919Y017"],"award-info":[{"award-number":["20220919Y017"]}],"id":[{"id":"10.13039\/100017363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ajp.2026.104854","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:39:05Z","timestamp":1769733545000},"page":"104854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Establishment and clinical application of a method for converting random quetiapine concentrations to steady-state trough concentrations"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6740-1023","authenticated-orcid":false,"given":"Jiezheng","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingshan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonglin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2026.104854_bib1","unstructured":"Chinese Society of Clinical Pharmacy. Guidelines for Therapeutic Drug Monitoring in Psychiatry (2023 Edition) [M]. Beijing: People's Medical Publishing House, 2023: 89-95."},{"issue":"5","key":"10.1016\/j.ajp.2026.104854_bib2","first-page":"923","article-title":"Quetiapine: a review of its use in the treatment of schizophrenia and bipolar disorder","volume":"42","author":"Citrome","year":"2020","journal-title":"J. ]. Clin. Ther."},{"key":"10.1016\/j.ajp.2026.104854_bib3","unstructured":"EMA. Quetiapine: Summary of Product Characteristics [Z]. 2023."},{"key":"10.1016\/j.ajp.2026.104854_bib4","unstructured":"FDA. Quetiapine Fumarate Extended-Release Tablets: Prescribing Information [Z]. 2022."},{"issue":"6","key":"10.1016\/j.ajp.2026.104854_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry - 2011 update [J]","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2026.104854_bib6","first-page":"233","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry \u2013 2022 update","volume":"55","author":"Hiemke","year":"2022","journal-title":"J. ]. Pharm."},{"issue":"6","key":"10.1016\/j.ajp.2026.104854_bib7","first-page":"233","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry \u2013 2022 update","volume":"55","author":"Hiemke","year":"2022","journal-title":"J. ]. Pharm."},{"issue":"12","key":"10.1016\/j.ajp.2026.104854_bib8","first-page":"1723","article-title":"Quetiapine in the treatment of eating disorders: a systematic review [J]","volume":"54","author":"Kaye","year":"2021","journal-title":"Int. J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.ajp.2026.104854_bib9","first-page":"121","article-title":"Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response","volume":"103","author":"Kirchheiner","year":"2004","journal-title":"J. ]. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.ajp.2026.104854_bib10","first-page":"1093","article-title":"Impact of smoking on quetiapine pharmacokinetics in patients with schizophrenia: a population pharmacokinetic analysis [J]","volume":"79","author":"Lee","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.ajp.2026.104854_bib11","first-page":"1093","article-title":"Impact of smoking on quetiapine pharmacokinetics in patients with schizophrenia: a population pharmacokinetic analysis [J]","volume":"79","author":"Lee","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.ajp.2026.104854_bib12","first-page":"166","article-title":"Quetiapine therapeutic drug monitoring: correlations with dose, efficacy, and adverse effects [J]","volume":"24","author":"de Leon","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2026.104854_bib13","first-page":"356","article-title":"Therapeutic drug monitoring of quetiapine: a 5-year experience [J]","volume":"38","author":"de Leon","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ajp.2026.104854_bib14","article-title":"Antipsychotic therapeutic drug monitoring in clinical practice: results from the TDM in Psychiatry Study Group","volume":"63","author":"de Leon","year":"2020","journal-title":"J. ]. Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.ajp.2026.104854_bib15","first-page":"145","article-title":"Pharmacokinetic interaction between quetiapine and its metabolite N-desmethylquetiapine","volume":"49","author":"Liu","year":"2023","journal-title":"J. ]. Chin. J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ajp.2026.104854_bib16","unstructured":"National Medical Products Administration. Quetiapine Tablets Instructions [Z]. 2023."},{"issue":"8","key":"10.1016\/j.ajp.2026.104854_bib17","first-page":"731","article-title":"Efficacy of quetiapine in bipolar depression: a double-blind, placebo-controlled study","volume":"59","author":"Nemeroff","year":"2002","journal-title":"J. ]. Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2026.104854_bib18","first-page":"731","article-title":"Efficacy and safety of quetiapine in the treatment of schizophrenia: a randomized controlled trial [J]","volume":"160","author":"Potkin","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2026.104854_bib19","first-page":"34","article-title":"Conversion of random quetiapine concentrations to trough concentrations: a pilot study [J]","volume":"50","author":"Smith","year":"2020","journal-title":"Psychopharmacol. Bull."},{"issue":"2","key":"10.1016\/j.ajp.2026.104854_bib20","first-page":"265","article-title":"Quetiapine: a review of its pharmacology and therapeutic potential in the treatment of schizophrenia","volume":"58","author":"Sparshatt","year":"1999","journal-title":"J. ]. Drugs"},{"issue":"4","key":"10.1016\/j.ajp.2026.104854_bib21","first-page":"511","article-title":"Effect of renal impairment on quetiapine and N-desmethylquetiapine pharmacokinetics: a population pharmacokinetic analysis","volume":"62","author":"Suzuki","year":"2023","journal-title":"J. ]. Clin. Pharmacokinet."},{"issue":"10283","key":"10.1016\/j.ajp.2026.104854_bib22","first-page":"1672","article-title":"Schizophrenia [J]","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"issue":"10335","key":"10.1016\/j.ajp.2026.104854_bib23","first-page":"1841","article-title":"Bipolar disorder [J]","volume":"399","author":"Taylor","year":"2022","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ajp.2026.104854_bib24","first-page":"1289","article-title":"Population pharmacokinetics of quetiapine and N-desmethylquetiapine in patients with schizophrenia: impact of age, sex, and comorbidities [J]","volume":"62","author":"Uchida","year":"2022","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ajp.2026.104854_bib25","first-page":"567","article-title":"Population pharmacokinetics of quetiapine and N-desalkylquetiapine in patients with schizophrenia: impact of age, sex, and comorbidities","volume":"63","author":"Uchida","year":"2023","journal-title":"J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.ajp.2026.104854_bib26","first-page":"1322","article-title":"In vitro and in vivo evaluation of quetiapine as a cytochrome P450 3A4 substrate and inhibitor","volume":"29","author":"Venkatakrishnan","year":"2001","journal-title":"J. ]. Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.ajp.2026.104854_bib27","first-page":"921","article-title":"Development of a nomogram for individualized quetiapine dosage adjustment based on therapeutic drug monitoring [J]","volume":"37","author":"Wang","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2026.104854_bib28","first-page":"156","article-title":"Influence of CYP3A4 and CYP3A5 gene polymorphisms on quetiapine pharmacokinetics in Chinese schizophrenia patients [J]","volume":"33","author":"Yu","year":"2023","journal-title":"Pharm. Genom."},{"issue":"2","key":"10.1016\/j.ajp.2026.104854_bib29","first-page":"189","article-title":"Therapeutic drug monitoring of quetiapine in pediatric schizophrenia patients: a systematic review [J]","volume":"33","author":"Zhang","year":"2024","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"11","key":"10.1016\/j.ajp.2026.104854_bib30","first-page":"1429","article-title":"Therapeutic drug monitoring of second-generation antipsychotics: a focus on clinical practice [J]","volume":"74","author":"Zoccali","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2026.104854_bib31","article-title":"Impact of comorbid diabetes on quetiapine pharmacokinetics: a retrospective cohort study","volume":"192","author":"Zoccali","year":"2022","journal-title":"J. ]. Diabetes Res. Clin. Pract."},{"issue":"7","key":"10.1016\/j.ajp.2026.104854_bib32","first-page":"1225","article-title":"Efficacy of quetiapine in generalized anxiety disorder: a 10-week randomized, double-blind, placebo-controlled study [J]","volume":"161","author":"Zohar","year":"2004","journal-title":"Am. J. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201826000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201826000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:15:05Z","timestamp":1776165305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201826000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"alternative-id":["S1876201826000274"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2026.104854","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment and clinical application of a method for converting random quetiapine concentrations to steady-state trough concentrations","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2026.104854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104854"}}